Dimension Biotechnologies

Dimension Biotechnologies is a spinout from the University of Bristol’s world-leading microvascular and kidney research group, Bristol Renal. The company focuses on developing innovative technologies for detecting microvascular health issues, particularly through glycocalyx sensing technology that aims to address significant healthcare challenges such as kidney disease and cardiovascular conditions.